Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Shares Issued (2019 - 2023)

Pliant Therapeutics (PLRX) has disclosed Shares Issued for 5 consecutive years, with $270.3 million as the latest value for Q1 2023.

  • Quarterly Shares Issued changed N/A to $270.3 million in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $270.3 million through Dec 2023, up 25.0% year-over-year, with the annual reading at $270.3 million for FY2023, 25.0% up from the prior year.
  • Shares Issued for Q1 2023 was $270.3 million at Pliant Therapeutics, up from $216.2 million in the prior quarter.
  • The five-year high for Shares Issued was $270.3 million in Q1 2023, with the low at -$140.8 million in Q4 2020.
  • Average Shares Issued over 5 years is $29.4 million, with a median of $198500.0 recorded in 2020.
  • The sharpest move saw Shares Issued crashed 96304.79% in 2020, then skyrocketed 30697.86% in 2022.
  • Over 5 years, Shares Issued stood at -$146000.0 in 2019, then plummeted by 96304.79% to -$140.8 million in 2020, then surged by 98.26% to -$2.4 million in 2021, then surged by 8949.82% to $216.2 million in 2022, then rose by 25.0% to $270.3 million in 2023.
  • According to Business Quant data, Shares Issued over the past three periods came in at $270.3 million, $216.2 million, and -$2.4 million for Q1 2023, Q3 2022, and Q4 2021 respectively.